To include your compound in the COVID-19 Resource Center, submit it here.

Zealand Pharma, Boehringer Ingelheim deal

Zealand granted Boehringer Ingelheim exclusive, worldwide rights to dual agonists of glucagon receptor (GCGR)

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE